This site is intended only for healthcare professionals resident in the United Kingdom
IBRANCE is indicated for the treatment of HR+/HER2-, locally advanced or mBC in combination with an AI or with fulvestrant in women who have received prior ET. In pre-and peri-menopausal women, the ET should be combined with a LHRH agonist.
Dr Erling Donnelly
Pfizer's commitment to the oncology community through the COVID-19 pandemic
Duration:
04:24
Dr Erling Donnelly, Head of Oncology, Pfizer UK on Pfizer's commitment to the oncology community through the COVID-19 pandemic.
"By clicking "confirm" to create an account, you confirm that the information you have provided above is correct, and you agree to (i) Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy and Cookie Policy; and (ii) Pfizer’s Website Terms of Use."
